In a new study, 60 mg of Cymbalta(R) (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.(1) The data were presented at the annual meeting of the American Academy of Pain Medicine (AAPM) in San Antonio, Texas. A total of 401 patients participated in the 12-week, double-blind ... Read more »
Cymbalta® Significantly Reduced Chronic Low Back Pain In New Study (PharmaceuticalOnline)
In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo. Read more »
Study shows Cymbalta reduces chronic low back pain (News-Medical-Net)
In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo. Read more »
Cymbalta(R) Significantly Reduced Chronic Low Back Pain in New Study (PR Newswire via Yahoo! Finance)
In a new study, 60 mg of Cymbalta® taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory average pain rating, compared with placebo. Read more »
FDA cancels meeting to review Lilly’s antidepressant as a new pain treatment (Minneapolis-St. Paul Star Tribune)
WASHINGTON - The Food and Drug Administration has canceled a meeting to review Eli Lilly's antidepressant Cymbalta for a new use against chronic pain. Read more »
